Hydranencephaly

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2177OMIM:605013Q04.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hydranencephaly is a rare and severe congenital condition in which the cerebral hemispheres of the brain are absent and replaced by sacs filled with cerebrospinal fluid. The brainstem, cerebellum, and other subcortical structures are typically preserved, which allows basic life-sustaining functions such as breathing, heart rate regulation, and some reflexive responses to continue. The condition is thought to result primarily from bilateral internal carotid artery occlusion or other vascular insults during fetal development, leading to massive destruction of previously formed brain tissue. Other proposed causes include intrauterine infections (such as toxoplasmosis or cytomegalovirus), genetic factors, or other teratogenic exposures. Hydranencephaly is sometimes referred to as hydranencephaly syndrome. At birth, infants with hydranencephaly may initially appear normal, as the head size can be within normal range or only mildly enlarged. However, within weeks to months, affected infants typically develop signs of increased intracranial pressure, progressive macrocephaly (enlargement of the head), irritability, spasticity, seizures, and severe developmental delay. Vision is usually absent or severely impaired, and most infants fail to achieve developmental milestones. Feeding difficulties are common, and many affected children require gastrostomy tube placement for nutritional support. The condition primarily affects the central nervous system, but secondary complications can involve the musculoskeletal system (contractures), respiratory system, and gastrointestinal system. There is no cure for hydranencephaly, and treatment is supportive and symptomatic. Management may include placement of a ventriculoperitoneal shunt to relieve hydrocephalus and control head enlargement, anticonvulsant medications for seizure management, physical therapy, and nutritional support. The prognosis is generally poor, with many affected infants not surviving beyond the first year of life, although some individuals have survived into childhood or rarely beyond with intensive supportive care. Early diagnosis is typically made through prenatal ultrasound or postnatal neuroimaging such as cranial ultrasound, CT scan, or MRI, which reveals the characteristic absence of cerebral hemispheres.

Clinical phenotype terms— hover any for plain English:

Infantile sensorineural hearing impairmentHP:0008610Abnormal corpus striatum morphologyHP:0010994Spastic diplegiaHP:0001264OpisthotonusHP:0002179Dilatation of the ventricular cavityHP:0006698Antenatal intracerebral hemorrhageHP:0007023Abnormal cerebral artery morphologyHP:0009145Abnormal dura mater morphologyHP:0010652Abnormal fontanelle morphologyHP:0011328Thalamic edemaHP:0025040Dysgenesis of the thalamusHP:0025099
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hydranencephaly.

View clinical trials →

No actively recruiting trials found for Hydranencephaly at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hydranencephaly community →

No specialists are currently listed for Hydranencephaly.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hydranencephaly.

Search all travel grants →NORD Financial Assistance ↗

Community

Open HydranencephalyForum →

No community posts yet. Be the first to share your experience with Hydranencephaly.

Start the conversation →

Latest news about Hydranencephaly

No recent news articles for Hydranencephaly.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hydranencephaly

What is Hydranencephaly?

Hydranencephaly is a rare and severe congenital condition in which the cerebral hemispheres of the brain are absent and replaced by sacs filled with cerebrospinal fluid. The brainstem, cerebellum, and other subcortical structures are typically preserved, which allows basic life-sustaining functions such as breathing, heart rate regulation, and some reflexive responses to continue. The condition is thought to result primarily from bilateral internal carotid artery occlusion or other vascular insults during fetal development, leading to massive destruction of previously formed brain tissue. Othe

How is Hydranencephaly inherited?

Hydranencephaly follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hydranencephaly typically begin?

Typical onset of Hydranencephaly is neonatal. Age of onset can vary across affected individuals.